Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check11 days agoChange DetectedThe page adds a recruitment-closure notice and new user-help sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study). The header formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision version is updated to v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a minor software revision. This change does not alter the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, signaling a new build of the study details template.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now displays Revision: v3.5.3, updating the version tag from v3.5.2. This indicates the current revision of the page has been refreshed.SummaryDifference0.1%

- Check61 days agoChange DetectedNew links/resources related to **Idiopathic Pulmonary Fibrosis**, including a **Genetic and Rare Diseases Information Center** reference, were added to the study page.SummaryDifference0.2%

- Check68 days agoChange DetectedAdded site revision label v3.5.2 and removed v3.5.0. This update does not modify trial content or user-facing information.SummaryDifference0.1%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.